Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Inventory (2019 - 2026)

Sunshine Biopharma filings provide 7 years of Inventory readings, the most recent being $13.5 million for Q4 2025.

  • On a quarterly basis, Inventory rose 19.45% to $13.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.5 million, a 19.45% increase, with the full-year FY2025 number at $13.5 million, up 19.45% from a year prior.
  • Inventory hit $13.5 million in Q4 2025 for Sunshine Biopharma, down from $14.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $14.1 million in Q3 2025 to a low of $26660.0 in Q1 2021.
  • Median Inventory over the past 5 years was $4.4 million (2023), compared with a mean of $5.6 million.
  • Biggest five-year swings in Inventory: surged 3014.0% in 2022 and later rose 19.45% in 2025.
  • Sunshine Biopharma's Inventory stood at $105650.0 in 2021, then surged by 3014.0% to $3.3 million in 2022, then soared by 74.31% to $5.7 million in 2023, then surged by 96.66% to $11.3 million in 2024, then rose by 19.45% to $13.5 million in 2025.
  • The last three reported values for Inventory were $13.5 million (Q4 2025), $14.1 million (Q3 2025), and $13.0 million (Q2 2025) per Business Quant data.